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Pulmonary adenocarcinoma is the most common type of lung cancer, and it may pres-ent as a focal ground-glass opacity (GGO) on thin-section computed tomography (CT) (1). Focal GGOs are classified as part-solid or pure according to the presence or ab-
sence of a solid component within the lesion (1).
A focal GGO is a complex diagnostic challenge because it may be the manifestation of 
a wide array of benign and malignant conditions, including inflammation, focal interstitial 
fibrosis, and neoplasm (2). Inflammation generally regresses in a short period of time (in 
weeks or a few months), either spontaneously or after proper therapy (2). Although benign, 
focal interstitial fibrosis may remain unchanged for a long time (2–5), while malignancies 
(most often pulmonary adenocarcinomas) tend to grow (6, 7).
Pulmonary adenocarcinomas exhibiting GGO are typically slow-growing lesions (8, 9), and 
their growth rates are difficult to characterize, particularly when size variations are solely as-
sessed as changes in two-dimensional (2D) diameters measured on an axial scan. The major 
limitation of this method is the asymmetric growth of lesions in the longitudinal plane. The high 
intra- and interobserver variabilities are additional drawbacks of 2D measurements (10–12).
Therefore, three-dimensional (3D) measurements are the current method of choice in the 
assessment of the growth rate of pulmonary lesions by calculating volumetric changes and 
doubling time (DT) (13). Although the accuracy and reproducibility of volumetric analysis in 
solid lung nodules have been widely demonstrated in the literature (14, 15), the results in 
GGOs are less consistent (16). However, it has been reported that the reproducibility of com-
puterized volumetric analysis is relatively high for GGOs ≥8 mm in diameter (17) and that CT 
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C H E S T  I M AG I N G
O R I G I N A L  A R T I C L E
PURPOSE 
We aimed to evaluate the growth pattern and doubling time (DT) of pulmonary adenocarci-
nomas exhibiting ground-glass opacities (GGOs) on multidetector computed tomography (CT).
METHODS
The growth pattern and DT of 22 pulmonary adenocarcinomas exhibiting GGOs were retrospec-
tively analyzed using three-dimensional semiautomatic software. Analysis of each lesion was 
based on calculations of volume and mass changes and their respective DTs throughout CT fol-
low-up. Three-dimensional segmentation was performed by a single radiologist on each CT scan. 
The same observer and another radiologist independently repeated the segmentation at the 
baseline and the last CT scan to determine the variability of the measurements. The relationships 
among DTs, histopathology, and initial CT features of the lesions were also analyzed.
RESULTS
Pulmonary adenocarcinomas presenting as GGOs exhibited different growth patterns: some le-
sions grew rapidly and some grew slowly, whereas others alternated between periods of growth, 
stability, or shrinkage. A significant increase in volume and mass that exceeded the coefficient of 
repeatability of interobserver variability was observed in 72.7% and 84.2% of GGOs, respectively. 
The volume-DTs and mass-DTs were heterogeneous throughout the follow-up CT scan (range, 
-4293 to 21928 and -3113 to 17020 days, respectively), and their intra- and interobserver variabil-
ities were moderately high. The volume-DTs and mass-DTs were not correlated with the initial 
CT features of GGOs; however, they were significantly shorter in invasive adenocarcinomas (P = 
0.002 and P = 0.001, respectively).
CONCLUSION
Pulmonary adenocarcinomas exhibiting GGOs show heterogeneous growth patterns with a trend 
toward a progressive increase in size. DTs may be useful for predicting tumor aggressiveness.
526 • November–December 2016 • Diagnostic and Interventional Radiology Borghesi et al.
images reconstructed with high-spatial-fre-
quency algorithms provide more accurate 
volumetric quantification of pulmonary nod-
ules, including GGOs (16, 18).
In addition to volume, de Hoop et al. (19) 
developed a quantitative method to mea-
sure the growth rate of GGOs on the basis of 
the concept of mass, calculated by multiply-
ing the nodule volume by the mean nodule 
density (i.e., mean CT number+1000). In 
their experience, mass and not volume 
should be the preferred parameter for the 
evaluation of growth in GGOs.
Recently, Song et al. (20) demonstrated 
that volume-DTs and mass-DTs were signifi-
cantly longer in pure and part-solid GGOs 
with a solid component of ≤5 mm than in 
part-solid GGOs with a solid component of 
>5 mm. Furthermore, Oda et al. (21) report-
ed that volume-DT may be helpful in differ-
entiating the histologic entities of GGOs.
Although the natural history and growth 
rate of the various lesions along the adeno-
carcinoma spectrum have been previous-
ly studied (6, 7, 22–25), to the best of our 
knowledge, there are no published studies in 
which the volume and mass changes of pul-
monary adenocarcinomas with GGOs (and 
their respective DTs) have been investigated 
using 3D software for each CT performed 
throughout follow-up (not just the baseline 
and last CT scan). Therefore, this study aimed 
to explore the growth pattern and rate of a 
group of pulmonary adenocarcinomas ap-
pearing as GGOs that were retrospectively 
analyzed with 3D commercial software to 
further understand their natural volumetric 
behavior. We also evaluated the intra- and in-
terobserver variabilities in volume, mass, and 
DT measurements as well as the relationship 
between DTs, histopathologic diagnosis, and 
initial CT features.
Methods
Patients and GGO lesion selection
Through a search on the department RIS/
PACS between January 2004 and December 
2014, all CT reports containing findings sug-
gestive of persistent GGOs, i.e., focal ground-
glass (or sub-solid) lesions unchanged or 
increased in size during a three-month or lon-
ger follow-up, were retrieved; both part-solid 
and pure GGOs were considered.
The search identified a total of 271 pa-
tients with one or more persistent GGOs. 
The study sample was selected according 
to the following inclusion criteria: a) GGO 
diameter (i.e., mean between the longest 
horizontal axis and its perpendicular di-
ameter on the largest cross-sectional area 
of the lesion) of ≥8 mm; b) two or more 
multidetector CT scans performed with the 
same scanner and same acquisition/recon-
struction protocol; c) thin-section 1 mm 
axial lung window images in DICOM format 
available; and d) histologic diagnosis made 
from surgical resection specimen accord-
ing to the International Association for the 
Study of Lung Cancer, American Thoracic 
Society, and European Respiratory Society 
(IASLC/ATS/ERS) classification of lung ade-
nocarcinoma (26).
Patients with interstitial pneumonia, a 
history of pulmonary aspergillosis, eosino-
philic pneumonia, organizing pneumonia, 
or undergoing steroid or chemotherapy 
treatment were excluded.
Applying such criteria, a total of 22 pul-
monary adenocarcinomas exhibiting GGOs 
were enrolled in the study, including 19 pa-
tients (12 males, 7 females) aged 49–84 years 
(mean, 67.4±10.4 years); three patients had 
two GGOs. The smoking habits and onco-
logic history of the 19 patients are listed in 
Table 1.
Image acquisition
Seventeen GGOs were scanned on a 
16-detector CT scanner (Somatom Sensa-
tion 16; Siemens) with the following pa-
rameters: collimation, 16×0.75 mm; beam 
pitch, 1.0; rotation time, 0.5 s; tube voltage, 
120 kVp; and tube current, 180 mAs. The 
remaining five GGOs were scanned using a 
128-detector CT scanner (Somatom Defini-
tion Flash; Siemens) with the following pa-
rameters: collimation, 128×0.6 mm; beam 
pitch, 1.2; rotation time, 0.5 s; tube voltage, 
120 kVp; and tube current, 110 mAs.
The acquisition, extending from the lung 
apex to lung base, was performed in inspi-
ratory apnea without spirometric control of 
the lung volume. The volume was recon-
structed as 1 mm thick sections, applying a 
sharp reconstruction algorithm and preset 
windowing, suited for lung parenchyma as-
sessment.
Main points
• Appropriate knowledge of growth patterns 
and rates of pulmonary adenocarcinomas 
presenting as ground-glass opacities (GGOs) 
is an important issue in the management of 
GGO lesions.
• Three-dimensional measurements are the 
current method of choice in the assessment 
of the growth rate of pulmonary nodules 
(including GGOs) by calculating volume 
and/or mass changes and their respective 
doubling times.
• Our three-dimensional analysis shows that 
pulmonary adenocarcinomas exhibiting 
GGOs have different patterns of growth: 
some lesions grow rapidly and some grow 
slowly, whereas others alternate between 
periods of growth, stability or shrinkage 
during follow-up.
• Volume and mass doubling times do not 
correlate with the initial CT features of 
the GGOs; however, they may provide 
information on GGO aggressiveness.
Table 1. Characteristics of the study patients (n=19)
Characteristics 
Age (years) 67.4±10.4
Gender
 Male 12 (63.2)
 Female 7 (36.8)
Smoking habits
 Current smoker 10 (52.6)
 Former smoker 8 (42.1)
 Never smoked 1 (5.3)
Oncologic history 10 (52.6)
 Lung cancer 6 (60)
Number of GGOs per patient
 One 16 (84.2)
 Two 3 (15.8)
Data are presented as number (%) or mean±standard deviation (SD). 
GGO, focal ground-glass opacity.
Computerized 3D analysis
The axial diameters, mean CT attenua-
tion, volume and mass changes of GGOs, 
and their volume-DT and mass-DT were cal-
culated by matching the baseline and each 
consecutive CT scan using 3D semiauto-
matic software (SAT module, classic version; 
Terarecon, Inc. ), which allows for the manu-
al delineation and correction of nodule con-
tours (Fig. 1). When the segmentations of 
two follow-up CT scans are matched, their 
results are simultaneously displayed and 
analyzed by the 3D software (Fig. 2).
Segmentation processing and 3D analysis 
were assessed visually and considered success-
ful when the GGO was completely outlined 
without any segmentation errors. A threshold 
attenuation value of −850 HU was used as the 
lower limit for GGO segmentation (27).
The diameter of each GGO at the baseline 
and at the last CT scan was determined by 
calculating the average of two diameters 
generated by the software at the end of 
segmentation (Figs. 1 and 2).
The mass was calculated by multiplying 
the GGO volume by the mean nodule den-
sity (i.e., mean CT number + 1000). Mass 
changes and mass-DT were calculated only 
in the GGOs in which CT scans had been ac-
quired without contrast.
Prior to the 3D analysis, visual assessment 
of the presence or absence of a solid com-
ponent within the GGO was performed at 
the baseline and at the last CT scan.
The 3D analysis and visual assessment 
of the solid component within GGOs were 
performed by a radiologist with 11 years 
of experience in thoracic imaging and five 
years of experience in using the software.
To assess variability of measurements, after 
an interval of at least six months, the same ob-
server and another radiologist (with 15 years 
of experience in CT imaging and three years 
of experience in using the software) inde-
pendently repeated the volume, mass, and DT 
measurements at the baseline and at the last 
CT scan of the GGOs in which both scans were 
performed without contrast.
For each GGO, the minimum time interval 
required to detect a significant growth (i.e., 
exceeding the interobserver coefficient of 
repeatability for the volume and mass mea-
surements) was also calculated.
The study was approved by the local ethics 
committee as a retrospective analysis. It did 
not alter the management of the patients, 
thus no specific consent was required. Howev-
er, informed consent had been obtained at the 
follow-up steps for both the CT scanning and 
the treatment of personal data.
Statistical analysis
The data are presented as the number 
(%) or the mean ± standard deviation for 
normally distributed data or as the medi-
an and the interquartile range (IQR) for not 
normally distributed data.
Bland-Altman analysis was used to deter-
mine the intra- and interobserver variability 
of the volume, mass, and DT measurements. 
For the intra- and interobserver variability, 
the relative differences in measurements 
were expressed as the percentage of the 
differences for each pair of measurements 
divided by the mean of two measurements 
(without log transformation). The limits for 
the percentage differences were presented 
as 95% confidence intervals. For interob-
server variability, the first measurement of 
the first observer was used.
We used the percentage rather than the 
absolute differences, as proposed originally 
by Bland and Altman (28), because the differ-
ences in measurements are not independent 
of the magnitude of the measurements. From 
the Bland-Altman analysis, we also obtained 
the coefficient of repeatability (CR) (28), which 
was calculated as 1.96 times the standard de-
viation of the differences between the mea-
surements and which is a measure of the 95% 
limit of agreement. In fact, the CR provides a 
value below which the differences between 
two repeated measurements would fall with 
a probability of 95%. Therefore, only differ-
ences above the CR should be considered 
significant.
To compare the measurement variability, 
the intraobserver and interobserver coef-
ficients of variation (CVs) for the volume, 
mass, and DTs were calculated for each 
GGO, and the Wilcoxon matched-pairs test 
was used to analyze the differences.
The Mann-Whitney U-test was used to 
compare the DTs of pure and part-solid 
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Figure 1. Axial CT images show the semiautomatic segmentation process of a ground-glass opacity 
(GGO). Step 1: select the lesion with a mouse click; an initial segmentation is automatically performed 
by the software. Step 2: choose a threshold CT attenuation value suited for GGOs (-850 HU as the 
lower limit in this study) and manually outline the lesion contours on all axial CT images. Step 3: 
check and correct any segmentation errors (arrow) with an editing tool. Step 4: the segmentation is 
completed, and the software automatically calculates the volume, diameters (i.e., the longest and 
widest perpendicular diameter on the largest cross-sectional area of the lesion), and 3D mean CT 
attenuation of the lesion.
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GGOs (calculated by matching the baseline 
and the last CT scan) and to analyze differ-
ences between the histologic subtypes. 
The Spearman correlation coefficient was 
applied to find correlations between the 
DT and CT features of GGOs (i.e., diameter, 
volume, mean CT attenuation, and mass) 
calculated on the baseline CT scan. For sta-
tistical analyses of the relationship between 
DTs, histopathologic diagnosis, and initial 
CT features, we considered only GGOs with 
positive DT values (calculated by matching 
the baseline and last CT scan).
We applied these tests because the vol-
ume, mass, and their respective DTs were 
not normally distributed.
Statistical analysis was performed with 
dedicated software (MedCalc Software). P 
values of <0.05 were considered statistically 
significant.
Results
All GGOs were histologically proven to 
be pulmonary adenocarcinomas: of 22 pul-
monary adenocarcinomas three were ade-
nocarcinoma in situ (AIS, 13.6%), five were 
minimally invasive adenocarcinoma (MIA, 
22.7%), and 14 were invasive adenocarcino-
ma (IA, 63.6%).
Each GGO was scanned 2–6 times (mean, 
3.5±1.3 times) before histologic diagnosis; 
16 GGOs (72.7%) were monitored more 
than twice. In 19 GGOs (86.4%), all the CT 
studies (baseline and each follow-up CT 
scan) were acquired without contrast, and 
in 14 of 19 GGOs (73.7%), three or more fol-
low-up CT scans were available.
The time interval between the baseline 
and last CT scan ranged from 126 to 1128 
days (median, 573 days; IQR, 256–823 days). 
The time interval between two consecutive 
CT examinations ranged from 61 to 670 days 
(median, 181 days; IQR, 123–279.8 days).
At the baseline CT, seven lesions (31.8%) 
were classified as pure GGOs and 15 (68.2%) 
were classified as part-solid GGOs; two pure 
GGOs developed a solid component during 
the follow-up period (Table 2). The diameter 
of GGOs ranged from 8 to 62 mm (median, 
16.5 mm; IQR, 12.9–31 mm) at baseline and 
from 12.5 to 63.7 mm (median, 20.8 mm; IQR, 
14.4–34.7 mm) at the last CT scan (Table 2).
For volume measurements, intraobserv-
er variability ranged from -19.3% to 14.3% 
(CR=16.8%) and interobserver variability 
ranged from -25.6% to 14.9% (CR=20.2%); for 
mass measurements, intraobserver variabili-
ty ranged from -13.4% to 11.1% (CR=12.2%) 
and interobserver variability ranged from 
-20.4% to 12.4% (CR=16.4%) (Fig. 3). The in-
traobserver CV for mass was significantly low-
er than the CV for volume (median, 0.02; IQR, 
0.01–0.04 vs. median, 0.03; IQR, 0.02–0.05; P 
= 0.006). Similarly, the interobserver CV for 
mass was significantly lower than the CV for 
volume (median, 0.02; IQR, 0.01–0.05 vs. me-
dian, 0.03; IQR, 0.01–0.06; P = 0.020).
For volume-DT, the intra- and interob-
server variability ranged from -47.5% to 
46.2% (CR=46.8%) and from -51.2% to 62.8% 
(CR=57%), respectively; for mass-DT, the in-
tra- and interobserver variability ranged from 
-55.5% to 54.8% (CR=55.1%) and from -63.2% 
to 48.5% (CR=55.8%), respectively (Fig. 4).
No significant difference was observed be-
tween the intraobserver CV  for the volume-DT 
and mass-DT (median, 0.09; IQR, 0.04-0.15 vs. 
median, 0.06; IQR, 0.02-0.16; P = 0.551). Simi-
larly, no significant difference was observed 
between interobserver CV for the volume-DT 
and mass-DT (median, 0.09; IQR, 0.04-0.14 vs. 
median, 0.09; IQR, 0.04-0.16; P = 0.899).
Segmentation and 3D computerized anal-
ysis were successfully performed in all cases. 
Based on the calculated volume and mass 
changes and their respective DTs on each 
follow-up CT scan, the 3D analysis of lesions 
Table 2. Characteristics of the 22 pulmonary adenocarcinomas showing GGOs at multidetector CT
Characteristic Baseline CT Last CT
GGO subtype
 Pure 7 (31.8) 5 (22.7)
 Part-solid 15 (68.2) 17 (77.3)
Diameter (mm) 16.5 (8–62) 20.8 (12.5–63.7)
GGOs with diameter <30 mm 16 (72.7) 13 (59)
Interval between baseline and last CT (days) 573 (126–1128)
Volume*
 Growing GGOs 16 (72.7)
 Volume increment (%) 84 (22–333)
 Doubling time (days) 728.5 (259–2196)
 Time interval to detect the growth (days) 170 (39–560)
Data are presented as number (%) or median (range). 
CT, computed tomography; GGO, focal ground-glass opacity.
*Changes from baseline to the last CT scan for growing lesions.
Figure 2. Example of the 3D analysis provided by the semiautomatic software in AIS presenting 
as a pure GGO. Baseline (left) and last follow-up CT scan (right). The interval between the two 
CT examinations was 823 days. In this case, the software calculated a significant relative volume 
variation of 44% (arrow) of the lesion with a volume-doubling time of 1560 days (wavy arrow), even 
though the axial diameters were stable (double headed arrow). This discrepancy is due to asymmetric 
growth of the lesion, predominantly in the longitudinal plane, as confirmed by the increased number 
of slices displaying the lesion (curved arrows). The white boxes show the GGO without purple overlay 
at the baseline and last follow-up CT scan.
included in this study revealed that pulmo-
nary adenocarcinomas presenting as GGOs 
exhibited different patterns of growth; some 
lesions grew rapidly and some grew slowly, 
whereas some alternated between periods 
of growth, stability or shrinkage (Figs. 5, 6). 
The volume-DTs and mass-DTs calculated on 
each follow-up CT scan ranged from -4293 
to 21928 days and from -3113 to 17020 days, 
respectively (Figs. 5, 6).
A significant increase in volume that ex-
ceeded the CR of interobserver variability 
(i.e., more than 20.2%) between the base-
line and last CT scan was observed in 16 
GGOs (72.7%; 3 pure and 13 part-solid). 
In this group exhibiting growth, includ-
ing one AIS, two MIA, and 13 IA, the mean 
volume-DT ranged from 259 to 2196 days 
(median, 728.5 days; IQR, 460.5–952.5 days), 
and the minimum time interval to detect 
the growth ranged from 39 to 560 days (me-
dian, 170 days; IQR, 101–256 days) (Table 2). 
In the remaining two part-solid GGOs (MIA 
and IA at histology) and four pure GGOs (2 
AIS and 2 MIA at histology), the 3D comput-
erized analysis did not detect a significant 
change in volume after a mean time inter-
val of 349±387.2 days. In this group, only 
one GGO (pure, AIS at histology) decreased 
in volume lower than the interobserver CR 
(2% after an interval of 126 days). The other 
five GGOs increased in volume by 4%–16% 
(volume-DT from 960 to 5968 days).
In the subgroup of 19 GGOs (6 pure and 
13 part-solid) scanned without contrast, the 
mean CT attenuation of GGOs ranged from 
-602.5 to -144.4 HU (mean, -381.7±133.6 
HU) at baseline and from -615.2 to -86.3 
HU (mean, -332.4±160.7 HU) at the last CT 
scan (Table 3). For each lesion, changes in 
mean CT attenuation throughout the fol-
low-up period are depicted in Fig. 7. In this 
subgroup, a significant increase in mass 
that exceeded the CR of interobserver vari-
ability (i.e., more than 16.4%) between the 
baseline and last CT scan was observed in 
16 GGOs (84.2%; 5 pure and 11 part-solid). 
In this group exhibiting growth, including 
one AIS, three MIA, and 12 IA, the mean 
mass-DT ranged from 226 to 4296 days 
(median, 844 days; IQR, 410.5–1063 days), 
and the minimum time interval to detect 
the growth ranged from 25 to 1008 days 
(median, 183.5 fays; IQR, 87.5–241.5 days). 
In the remaining two part-solid GGOs (MIA 
and IA at histology) and one pure GGO (AIS 
at histology), the 3D computerized analysis 
did not detect a significant change in mass 
after a mean time interval of 148.7±28.7 
days. In this group, only one GGO (pure, AIS 
at histology) decreased in mass lower than 
the interobserver CR (2% after an interval of 
126 days). The other two GGOs increased in 
mass by 7% and 9% with a mass-DT of 1963 
and 1148 days, respectively.
No significant difference was observed be-
tween the volume-DT of pure and part-solid 
GGOs, as classified on the baseline CT (P = 
0.392); however, the volume-DT of IA was 
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Figure 3. Bland-Altman plots show the intraobserver (left) and interobserver (right) variability of the volume (top) and mass measurements (bottom). The 
solid line represents the mean of differences. The dashed lines represent the upper and lower limits of agreement. SD, standard deviation; CR, coefficient 
of repeatability.
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Figure 4. Bland-Altman plots show the intraobserver (left) and interobserver (right) variabilities of the volume- (top) and mass-doubling time (bottom) 
measurements. The solid line represents the mean of differences. The dashed lines represent the upper and lower limits of agreement. SD, standard 
deviation; CR, coefficient of repeatability.
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Figure 5. Growth pattern of the 22 pulmonary adenocarcinomas showing GGOs based on volumetric changes during the follow-up (an overall number of 
77 consecutive CT examinations) (left). Volume-doubling time variations throughout the follow-up CT in the 16 GGOs scanned three times or more (right). 
Dashed lines, pure GGOs; dotted lines, part-solid GGOs; solid lines, pure GGOs that developed a solid component during follow-up.
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significantly shorter than that of AIS and 
MIA (median, 728.5 days; IQR, 418–917 days 
vs. median, 1560 days; IQR,  1195.8–2434.5 
days; P = 0.002). No significant difference was 
observed between the mass-DT of pure and 
part-solid GGOs, as classified on the baseline 
CT (P = 0.853); however, the mass-DT of IA was 
also significantly shorter than that of AIS and 
MIA (median, 657 days; IQR, 364–962 days 
vs. median, 1336 days; IQR, 1075–2357 days, 
P = 0.001).
No correlation was found between vol-
ume-DT or mass-DT and diameter (r=-0.016, 
P = 0.946), volume (r=-0.096, P = 0.678), 
mean CT attenuation (r=-0.366, P = 0.135), 
and mass (r=-0.150, P = 0.553) calculated on 
the baseline CT scans.
Discussion
Appropriate knowledge of growth patterns 
and rates of pulmonary adenocarcinomas 
manifesting as GGOs is an important issue in 
lung cancer screening and impacts guidelines 
for nodule management (29, 30). Many stud-
ies on the natural history of GGOs are based 
on changes of the longest diameter mea-
sured on 2D axial CT scan, and DTs have been 
calculated by applying the modified Schwartz 
formula (6, 7, 24, 25). In two recent studies, 
the majority of GGOs (73.7% and 85.4%, re-
spectively) did not grow during a long-term 
follow-up of more than two years (24, 25).
However, some malignant lesions have 
asymmetric growth, resulting in minimal 
changes in the longest diameter but an in-
crease in the overall volume (14). Therefore, 
only 3D computerized analysis should be 
considered sufficiently accurate for assess-
ing the growth pattern and calculating DTs 
in pulmonary lesions (13, 14).
This observation is clearly illustrated in 
one of our GGOs in which 3D analysis, per-
formed by matching the baseline and 823-
day follow-up CT scan, exhibited a relative 
volume variation of 44% without a signifi-
cant change in the axial diameters (Fig. 2).
Initial studies on computerized volumet-
ric analysis performed on chest phantoms 
demonstrated a significantly higher mea-
surement inaccuracy in GGOs than in solid 
nodules (16). The segmentation of GGOs 
is hampered by the small density gap be-
tween the lesion and surrounding normal 
parenchyma. In addition, volumetric anal-
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Figure 7. Changes in mean CT attenuation throughout the follow-up CT period (an overall number 
of 68 consecutive CT examinations) in the 19 pulmonary adenocarcinomas exhibiting GGOs and 
scanned without contrast. Dashed lines, pure GGOs; dotted lines, part-solid GGOs; solid lines, pure 
GGOs that developed a solid component during the follow-up.
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ysis may be influenced by the 3D software 
utilized, size of the lesion, scanning and 
reconstruction protocols, and depth of the 
patient’s inspiration (14–16, 31).
However, relatively recent studies 
demonstrated that volumetric analysis may 
play a significant role in GGO monitoring 
(17, 18). Oda et al. (17) showed promising 
results on the accuracy and reproducibil-
ity of volumetric analysis of GGOs ≥8 mm. 
Nonetheless, the intra- and interobserver 
variability were higher than those in studies 
on solid nodules (13). A newly developed 
method to assess the growth rate of GGOs 
is through the calculation of the mass; this 
parameter is considered advantageous for 
GGO monitoring because it combines volu-
metric and densitometric evaluation and is 
subject to less variability than volume (19).
In our study, all GGOs were successfully 
segmented despite the difficulties reported 
in the literature (16). Our intra- and interob-
server variability were greater than those 
reported by Kim et al. (32) using commer-
cial semiautomatic software without man-
ual editing and margin drawing. In their 
study, intraobserver volume and mass mea-
surement variability for reader 1 ranged 
from -7.6% to 8.5% and from -8.1% to 8.7%, 
respectively, whereas interobserver volume 
and mass measurement variability ranged 
from -11.7% to 18.1% and from -17.5% to 
11.8%, respectively. Such differences are 
likely to be related to the influence of man-
ual correction used in our segmentations. 
However, in clinical practice, the variabili-
ty of measurements after manual editing 
may be reduced because the baseline and 
follow-up CT scan are simultaneously dis-
played by software (Fig. 2); therefore, differ-
ences between the two segmentations may 
be promptly identified and corrected.
Our interobserver variability for volume 
and mass measurements was lower than that 
recently reported by Scholten et al. (33) using 
semiautomatic segmentation software with 
an editing tool. In their study, interobserver 
volume and mass measurement variabili-
ty ranged from -64.4% to 72.1% and from 
-43.4% to 53.4%, respectively. Their results 
may be mainly affected by the algorithm 
selected for CT image reconstruction (mod-
erately soft kernel) (16, 18) and the significant 
difference in experience of the two observers 
(greater than that in our study).
With regard to the CV comparison, Kim et 
al. (32) found no significant difference be-
tween volume and mass measurement vari-
ability. Conversely, our results demonstrate 
that mass measurements are subject to less 
variability than volume measurements, in 
line with previous data reported by de Hoop 
et al. (19) using in-house manual software; 
however, our intra- and interobserver CVs 
were lower than those reported by de Hoop 
et al. (19). This difference may be related to 
the type of 3D software used (semiautomat-
ic vs. manual), the algorithm selected for CT 
image reconstruction (sharp vs. moderately 
soft kernel) (16, 18), and the size of GGOs an-
alyzed (larger in our study) (17).
We also found that the intra- and interob-
server variability in volume-DT and mass-DT 
measurements (not previously reported) 
were moderately high (Fig. 4), and there was 
no significant difference between their CVs.
To the best of our knowledge, this study is 
the first in which 3D analysis of growth pat-
terns and the rates of a group of pulmonary 
adenocarcinomas presenting as GGOs was 
performed using commercial semiautomat-
ic software while considering each CT per-
formed during follow-up (not just the base-
line and last scan). This analysis allowed us to 
demonstrate that adenocarcinomas showing 
GGOs have different growth patterns and 
rates (Figs. 5, 6), which were not correlated 
with the majority of initial CT features, such 
as nodule consistency (pure or part-solid), 
diameter, volume, mean CT attenuation, and 
mass. In fact, some GGOs grew faster (time in-
tervals to detect growth for volume and mass 
measurements of 39 and 25 days, respective-
ly) and some grew more slowly (time inter-
vals to detect growth for volume and mass 
measurements of 560 and 1008 days, respec-
tively), whereas others alternated between 
periods of stability, growth, or shrinkage with 
or without a significant increase in size during 
follow-up. Furthermore, the volume-DTs and 
mass-DTs of some GGOs varied considerably 
throughout the follow-up period (Figs. 5, 6).
These different growth patterns and rates 
might be due to various factors: interscan 
differences (i.e., variable degrees of inspira-
tory apnea, patient position, intraobserver 
variability), which might justify the variation 
of measurements in some cases (32, 34); al-
veolar collapse or central fibrosis, which may 
account for the decrease in volume and mass 
(35); and molecular mutations switching the 
lesion toward a more aggressive type, which 
might explain the rapid growth.
In our study, the volume-DT of growing 
GGOs between the baseline and last CT scan 
ranged from 259 to 2196 days (median, 728.5 
days; IQR, 460.5–952.5 days). This finding is in 
line with previous literature data (7, 25), al-
though the observed volume-DT was longer 
than that reported by Oda et al. (21) (mean, 
486.4±368.6 days; range, 89–1583 days) us-
ing in-house semi-automated software. Such 
differences might be related to the different 
sample size and different study design, as we 
included only GGOs greater than or equal to 
8 mm, and each lesion was examined during 
follow-up with the same scanner and same 
acquisition/reconstruction protocol.
Conversely, the volume-DTs and mass-DTs 
of growing GGOs in our study were shorter 
than those reported by Song et al. (20). We 
attribute this difference to the different pop-
ulation (in their study, only patients without 
a history of previous malignancy were in-
cluded) and the different sample size (only 
histologically confirmed GGOs greater than 
or equal to 8 mm were included in our study).
In contrast to the literature data (20, 21), 
we did not observe statistically significant 
differences between the DTs of part-solid 
GGOs and DTs of pure GGOs. With regard to 
mass-DT, the lack of a significant difference 
between pure and part-solid GGOs, as clas-
sified on the baseline CT, can be explained 
because some part-solid lesions in our series 
Table 3. Characteristics of the 19 pulmonary adenocarcinomas showing GGOs at multidetector CT 
without contrast
Characteristic Baseline CT Last CT
GGO subtype
 Pure 6 (31.6) 4 (21.1)
 Part-solid 13 (68.4) 15 (78.9)
Mean CT attenuation (HU) −381.7±133.6 −332.4±160.7
Interval between baseline and last CT (days) 584 (126-1128)
Mass*
 Growing GGOs 16 (84.2)
 Mass increment (%) 78.5 (19–483)
 Doubling time (days) 844 (226–4296)
 Time interval to detect the growth (days) 183.5 (25–1008)
Data are presented as number (%), mean±standard deviation, or median (range). 
GGO, focal ground-glass opacity.
*Changes from baseline to the last CT scan for growing lesions. 
showed a reduction in mean CT attenuation 
during the follow-up (Fig. 7). This finding 
might be related to a difference in volumet-
ric growth between the ground-glass and 
the solid component. In fact, if the growth of 
the ground-glass component in a part-solid 
GGO is greater than the growth of the solid 
component, it might reduce mean CT atten-
uation. Furthermore, two of the fastest grow-
ing lesions included in our study were pure 
at the baseline CT but developed a solid 
component during the follow-up (Figs. 5, 6).
Nevertheless, our study demonstrated 
that DT may provide information on GGO 
aggressiveness because the volume-DTs 
and mass-DTs of IA were significantly short-
er than those of MIA and AIS.
In contrast to our data, Song et al. (20) 
found no significant difference in median 
volume-DT and mass-DT among AIS, MIA, 
and IA. We attribute this difference to the 
different patients and GGO selection.
This study had several limitations. First, it 
was performed retrospectively, and the time 
intervals between two consecutive follow-up 
CT scans were heterogeneous because no 
specific recommendations for the manage-
ment of GGOs were available at the time of 
each CT examination and only thin-section 
CTs (1 mm thick) were selected. Second, only 
a small number of GGOs were included be-
cause the inclusion criteria were quite strict. 
Third, the lesion size was not small (27.3% 
were greater than 3 cm at the baseline CT), 
although a larger size may have reduced the 
variability of the measurements. Fourth, only 
the resected GGOs histologically proven to be 
adenocarcinomas were analyzed; therefore, 
nonresected lesions were not represented in 
our data. Fifth, more than 50% of our patients 
had a history of malignancy; although this 
group has a risk factor for fast-growing GGOs, 
we believe that it more appropriately rep-
resents daily clinical practice. Sixth, CT scans 
were performed without spirometric control 
of lung volume; however, respiratory gating 
is not easy to apply in clinical settings. Sev-
enth, the 3D software used in our study did 
not have a dedicated vessel extraction func-
tion; therefore, the small vessels located with-
in GGO lesions were not excluded during the 
segmentation process. However, the vessels 
contiguous to lesion contours were removed 
with the manual editing tool.
In conclusion, pulmonary adenocarcino-
mas presenting as GGOs show heteroge-
neous growth patterns with a trend toward 
a progressive increase in size over time. 
Despite their drawbacks, the calculation of 
volume-DT and mass-DT in GGOs may be 
useful for predicting tumor aggressiveness.  
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